Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Prepubertal Children With Growth Failure Associated With Primary IGF-1 Deficiency: A Phase 3, Randomized, Open Label, Observation-Controlled, Multicenter, Parallel-Dose Comparison Trial
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Mecasermin (Primary)
- Indications Short stature
- Focus Therapeutic Use
- Sponsors Ipsen
- 21 Oct 2013 New trial record